Asia Pacific Precision Oncology Market Size & Outlook

The precision oncology market in Asia Pacific is expected to reach a projected revenue of US$ 50,287.5 million by 2030. A compound annual growth rate of 10.9% is expected of Asia Pacific precision oncology market from 2025 to 2030.
Revenue, 2024 (US$M)
$27,061.3
Forecast, 2030 (US$M)
$50,287.5
CAGR, 2025 - 2030
10.9%
Report Coverage
Asia Pacific

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific precision oncology market, 2018-2030 (US$M)

Asia Pacific precision oncology market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific precision oncology market highlights

  • The Asia Pacific precision oncology market generated a revenue of USD 27,061.3 million in 2024.
  • The market is expected to grow at a CAGR of 10.9% from 2025 to 2030.
  • In terms of segment, therapeutics was the largest revenue generating product in 2024.
  • Diagnostics is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, India is expected to register the highest CAGR from 2025 to 2030.


Asia Pacific data book summary

Market revenue in 2024USD 27,061.3 million
Market revenue in 2030USD 50,287.5 million
Growth rate10.9% (CAGR from 2025 to 2030)
Largest segmentTherapeutics
Fastest growing segmentDiagnostics
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDiagnostics, Therapeutics
Key market players worldwideThermo Fisher Scientific Inc, Invitae Corp, Qiagen NV, Illumina Inc, Exact Sciences Corp, Rain Oncology, Strata Oncology, Xilis, Variantyx, BioServe, Relay Therapeutics, Acrivon Therapeutics


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 23.4% of the global precision oncology market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 50,287.5 million by 2030.

Therapeutics was the largest segment with a revenue share of 78.78% in 2024. Horizon Databook has segmented the Asia Pacific precision oncology market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.


The launch of the Quad Cancer Moonshot initiative by the United States, Australia, India, and Japan is set to strengthen the cancer care ecosystem in the Indo-Pacific. This initiative focuses on improving health infrastructure, expanding research collaborations, and enhancing support for cancer prevention, detection, and treatment. The emphasis on cervical cancer as a starting point, along with the broader commitment to address other cancer types, is expected to drive advancements in precision oncology, improve access to cutting-edge treatments, and foster the development of region-specific diagnostic and therapeutic solutions.


No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Precision Oncology Market Companies

Name Profile # Employees HQ Website
Acrivon Therapeutics View profile 51-100 Cambridge, Massachusetts, United States, North America http://www.acrivon.com/
Relay Therapeutics View profile 251-500 Cambridge, Massachusetts, United States, North America http://relaytx.com/
BioServe View profile 51-100 Beltsville, Maryland, United States, North America https://bioserve.com
Variantyx View profile 101-250 Framingham, Massachusetts, United States, North America https://www.variantyx.com
Xilis View profile 51-100 Durham, North Carolina, United States, North America http://www.xilis.net
Strata Oncology View profile 51-100 Ann Arbor, Michigan, United States, North America http://www.strataoncology.com/
Rain Oncology View profile 101-250 Newark, California, United States, North America https://www.rainoncology.com
Invitae Corp View profile 1700 1400 16th Street, San Francisco, CA, United States, 94103 https://www.invitae.com
Exact Sciences Corp View profile 6600 5505 Endeavor Lane, Madison, WI, United States, 53719 https://www.exactsciences.com
Qiagen NV View profile 5900 Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL https://www.qiagen.com
Illumina Inc View profile 9300 5200 Illumina Way, San Diego, CA, United States, 92122 https://www.illumina.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com

Asia Pacific precision oncology market size, by country, 2018-2030 (US$M)

Asia Pacific Precision Oncology Market Outlook Share, 2024 & 2030 (US$M)

Asia Pacific precision oncology market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online